He Wei-Wu 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-21 4:26 pm Purchase |
2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,761,349 18.950% |
2,761,349 (New Position) |
Filing |